Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review

Gerhardus A, Schleberger H, Schlegelberger B, Gadzicki D (2007)
EUROPEAN JOURNAL OF HUMAN GENETICS 15(6): 619-627.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ;
Abstract / Bemerkung
As sequence analysis for BRCA1 and BRCA2 mutations is both time- and cost-intensive, current strategies often include scanning techniques to identify fragments containing genetic sequence alterations. However, a systematic assessment of the diagnostic accuracy has been lacking so far. Here, we report on a systematic review to assess the internal and external validity of current scanning techniques. Inclusion criteria were: controlled design, investigators blinded, and tests suitable as a scanning tool for the whole genes BRCA1 and BRCA2. Outcome parameters were sensitivity, specificity, and positive and negative predictive values compared to direct sequencing. Out of 3816 publications, 10 studies reporting on 12 methods met our inclusion criteria. The internal and external validity of most of these studies was limited. Sensitivities were reported to be 100% for enzymatic mutation detection (EMD), multiple-dye cleavase fragment length polymorphism (MD-CFLP), fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE), RNA-based sequencing, restriction endonuclease fingerprinting-single strand conformation polymorphism (REF-SSCP), stop codon (SC) assay, and denaturing high-performance liquid chromatography (DHPLC). Sensitivity was 50-96% for SSCP, 88-91% for two-dimensional gene scanning (TDGS), 76% for conformation-sensitive gel electrophoresis (CSGE), 75% for protein truncation test (PTT), and 58% for micronucleus test (MNT). Specificities close to 100% were reported, except for MNT. PTT and SC assay are only able to detect truncating mutations. Most studies were designed to introduce new experimental approaches or modifications of established methods and require further evaluation. F-CSGE, REF-SSCP, RNA-based sequencing, EMD, and MD-CFLP will need further evaluation before their use in a routine setting can be considered. SSCP, MNT, PTT, CSGE, and TDGS cannot be recommended because of their low sensitivity. DHPLC outperforms all other methods studied. However, none of the four studies evaluating DHPLC was performed on BRCA2.
Erscheinungsjahr
Zeitschriftentitel
EUROPEAN JOURNAL OF HUMAN GENETICS
Band
15
Zeitschriftennummer
6
Seite
619-627
ISSN
eISSN
PUB-ID

Zitieren

Gerhardus A, Schleberger H, Schlegelberger B, Gadzicki D. Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review. EUROPEAN JOURNAL OF HUMAN GENETICS. 2007;15(6):619-627.
Gerhardus, A., Schleberger, H., Schlegelberger, B., & Gadzicki, D. (2007). Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review. EUROPEAN JOURNAL OF HUMAN GENETICS, 15(6), 619-627. doi:10.1038/sj.ejhg.5201806
Gerhardus, A., Schleberger, H., Schlegelberger, B., and Gadzicki, D. (2007). Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review. EUROPEAN JOURNAL OF HUMAN GENETICS 15, 619-627.
Gerhardus, A., et al., 2007. Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review. EUROPEAN JOURNAL OF HUMAN GENETICS, 15(6), p 619-627.
A. Gerhardus, et al., “Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review”, EUROPEAN JOURNAL OF HUMAN GENETICS, vol. 15, 2007, pp. 619-627.
Gerhardus, A., Schleberger, H., Schlegelberger, B., Gadzicki, D.: Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review. EUROPEAN JOURNAL OF HUMAN GENETICS. 15, 619-627 (2007).
Gerhardus, Ansgar, Schleberger, Henriette, Schlegelberger, Brigitte, and Gadzicki, Dorothea. “Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review”. EUROPEAN JOURNAL OF HUMAN GENETICS 15.6 (2007): 619-627.

40 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in BRCA1 and BRCA2.
Hwang SM, Lee KC, Lee MS, Park KU., Cancer Res Treat 50(1), 2018
PMID: 28392550
A novel loss-of-function heterozygous BRCA2 c.8946_8947delAG mutation found in a Chinese woman with family history of breast cancer.
Ma J, Yang J, Jian W, Wang X, Xiao D, Xia W, Xiong L, Ma D., J Cancer Res Clin Oncol 143(4), 2017
PMID: 28058502
Recent omics technologies and their emerging applications for personalised medicine.
Kim DH, Kim YS, Son NI, Kang CK, Kim AR., IET Syst Biol 11(3), 2017
PMID: 28518059
Microfluidic Synthesis of Nanoparticles and their Biosensing Applications.
Boken J, Soni SK, Kumar D., Crit Rev Anal Chem 46(6), 2016
PMID: 27070948
Simultaneous detection of BRCA mutations and large genomic rearrangements in germline DNA and FFPE tumor samples.
Enyedi, Jaksa G, Pintér L, Sükösd F, Gyuris Z, Hajdu A, Határvölgyi E, Priskin K, Haracska L., Oncotarget 7(38), 2016
PMID: 27533253
Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and/or ovarian cancer.
Trujillano D, Weiss ME, Schneider J, Köster J, Papachristos EB, Saviouk V, Zakharkina T, Nahavandi N, Kovacevic L, Rolfs A., J Mol Diagn 17(2), 2015
PMID: 25556971
Two novel frameshift mutations in BRCA2 gene detected by next generation sequencing in a survey of Spanish patients of breast cancer.
Hernan I, Mañé B, Borràs E, de Sousa Dias M, Llort G, Yagüe C, Gamundi MJ, Arcusa À, Carballo M., Clin Transl Oncol 17(7), 2015
PMID: 25586199
Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2.
Dean M, Boland J, Yeager M, Im KM, Garland L, Rodriguez-Herrera M, Perez M, Mitchell J, Roberson D, Jones K, Lee HJ, Eggebeen R, Sawitzke J, Bass S, Zhang X, Robles V, Hollis C, Barajas C, Rath E, Arentz C, Figueroa JA, Nguyen DD, Nahleh Z., Gigascience 4(), 2015
PMID: 26543556
The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective.
Dutil J, Golubeva VA, Pacheco-Torres AL, Diaz-Zabala HJ, Matta JL, Monteiro AN., Breast Cancer Res Treat 154(3), 2015
PMID: 26564481
Genetic testing in hereditary breast and ovarian cancer using massive parallel sequencing.
Ruiz A, Llort G, Yagüe C, Baena N, Viñas M, Torra M, Brunet A, Seguí MA, Saigí E, Guitart M., Biomed Res Int 2014(), 2014
PMID: 25136594
Fertility preservation in breast cancer patients.
El Hachem H, Atallah D, Grynberg M., Future Oncol 10(10), 2014
PMID: 25303056
Serous adenocarcinoma of the ovary diagnosed during ultrasound evaluation for fertility preservation.
Hachem HE, Poulain M, Höher M, Fanchin R, Frydman R, Grynberg M., Future Oncol 10(12), 2014
PMID: 25386809
Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients.
Benesova L, Belsanova B, Suchanek S, Kopeckova M, Minarikova P, Lipska L, Levy M, Visokai V, Zavoral M, Minarik M., Anal Biochem 433(2), 2013
PMID: 22750103
Nonoptical massive parallel DNA sequencing of BRCA1 and BRCA2 genes in a diagnostic setting.
Costa JL, Sousa S, Justino A, Kay T, Fernandes S, Cirnes L, Schmitt F, Schmitt F, Machado JC., Hum Mutat 34(4), 2013
PMID: 23315985
A new rapid methodological strategy to assess BRCA mutational status.
Vuttariello E, Borra M, Calise C, Mauriello E, Greggi S, Vecchione A, Biffali E, Chiappetta G., Mol Biotechnol 54(3), 2013
PMID: 23354980
BRCA1/2 testing: uptake, phenocopies, and strategies to improve detection rates in initially negative families.
Fischer C, Engel C, Sutter C, Zachariae S, Schmutzler R, Meindl A, Heidemann S, Grimm T, Goecke TO, Debatin I, Horn D, Wieacker P, Gadzicki D, Becker K, Schäfer D, Stock F, Voigtländer T, German Consortium for Hereditary Breast and Ovarian Cancer., Clin Genet 82(5), 2012
PMID: 21919902
Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing.
Hernan I, Borràs E, de Sousa Dias M, Gamundi MJ, Mañé B, Llort G, Agúndez JA, Blanca M, Carballo M., J Mol Diagn 14(3), 2012
PMID: 22426013
Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.
Vaca-Paniagua F, Alvarez-Gomez RM, Fragoso-Ontiveros V, Vidal-Millan S, Herrera LA, Cantú D, Bargallo-Rocha E, Mohar A, López-Camarillo C, Pérez-Plasencia C., PLoS One 7(5), 2012
PMID: 22655046
High sensitivity for BRCA1/2 mutations in breast/ovarian kindreds: are there still other breast/ovary genes to be discovered?
Smith MJ, Gifford FL, Lalloo F, Newman WG, Evans DG., Breast Cancer Res Treat 134(2), 2012
PMID: 22752287
Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer.
Kim H, Cho DY, Choi DH, Choi SY, Shin I, Park W, Huh SJ, Han SH, Lee MH, Ahn SH, Son BH, Kim SW, Korean Breast Cancer Study Group, Haffty BG., Breast Cancer Res Treat 134(3), 2012
PMID: 22798144
CFTR transcription defects in pancreatic sufficient cystic fibrosis patients with only one mutation in the coding region of CFTR.
Sheridan MB, Hefferon TW, Wang N, Merlo C, Milla C, Borowitz D, Green ED, Mogayzel PJ, Cutting GR., J Med Genet 48(4), 2011
PMID: 21097845
Advantage of high-resolution melting curve analysis over conformation-sensitive gel electrophoresis for mutational screening of BRCA1 and BRCA2 genes.
de Juan Jiménez I, Cardeñosa EE, Suela SP, González EB, Trejo DS, Lluch OF, Gilabert PB., Clin Chim Acta 412(7-8), 2011
PMID: 21147080
Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations.
De Leeneer K, Hellemans J, De Schrijver J, Baetens M, Poppe B, Van Criekinge W, De Paepe A, Coucke P, Claes K., Hum Mutat 32(3), 2011
PMID: 21305653
Microfluidic reactors for diagnostics applications.
McCalla SE, Tripathi A., Annu Rev Biomed Eng 13(), 2011
PMID: 21568712
BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer.
Diaz-Cruz ES, Cabrera MC, Nakles R, Rutstein BH, Furth PA., Breast Dis 32(1-2), 2010
PMID: 21778574
A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysis.
Coulet F, Pires F, Rouleau E, Lefol C, Martin S, Colas C, Cohen-Haguenauer O, Giurgea I, Fajac A, Noguès C, Demange L, Hardouin A, Lidereau R, Soubrier F., Genet Test Mol Biomarkers 14(5), 2010
PMID: 20858050
An ELISA-based high throughput protein truncation test for inherited breast cancer.
Lim MJ, Foster GJ, Gite S, Ostendorff HP, Narod S, Rothschild KJ., Breast Cancer Res 12(5), 2010
PMID: 20920338
Diagnostic guidelines for high-resolution melting curve (HRM) analysis: an interlaboratory validation of BRCA1 mutation scanning using the 96-well LightScanner.
van der Stoep N, van Paridon CD, Janssens T, Krenkova P, Stambergova A, Macek M, Matthijs G, Bakker E., Hum Mutat 30(6), 2009
PMID: 19370767
c.1810C>T polymorphism of NTRK1 gene is associated with reduced survival in neuroblastoma patients.
Lipska BS, Drozynska E, Scaruffi P, Tonini GP, Izycka-Swieszewska E, Zietkiewicz S, Balcerska A, Perek D, Chybicka A, Biernat W, Limon J., BMC Cancer 9(), 2009
PMID: 20003389
Mutation detection using ENDO1: application to disease diagnostics in humans and TILLING and Eco-TILLING in plants.
Triques K, Piednoir E, Dalmais M, Schmidt J, Le Signor C, Sharkey M, Caboche M, Sturbois B, Bendahmane A., BMC Mol Biol 9(), 2008
PMID: 18433472
Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations.
Haitian Z, Yunfei L, Jian Z, Jian L, Qinghua L, Fuqiang W., Breast 17(6), 2008
PMID: 18835712
"Sequencing-grade" screening for BRCA1 variants by oligo-arrays.
Monaco A, Menolascina F, Zhao Y, Tommasi S, Sabatino M, Fasano R, Paradiso A, Marincola FM, Wang E., J Transl Med 6(), 2008
PMID: 18973698
Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.
Meiser B, Tucker K, Friedlander M, Barlow-Stewart K, Lobb E, Saunders C, Mitchell G., Breast Cancer Res 10(6), 2008
PMID: 19090970

39 References

Daten bereitgestellt von Europe PubMed Central.

BRCA1 and BRCA2: 1994 and beyond.
Narod SA, Foulkes WD., Nat. Rev. Cancer 4(9), 2004
PMID: 15343273
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W., Science 266(5182), 1994
PMID: 7545954
Identification of the breast cancer susceptibility gene BRCA2.
Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G., Nature 378(6559), 1995
PMID: 8524414
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.
Antoniou AC, Pharoah PD, McMullan G, Day NE, Stratton MR, Peto J, Ponder BJ, Easton DF., Br. J. Cancer 86(1), 2002
PMID: 11857015
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
Roa BB, Boyd AA, Volcik K, Richards CS., Nat. Genet. 14(2), 1996
PMID: 8841191
Impact of gene patents on the cost-effective delivery of care: the case of BRCA1 genetic testing.
Sevilla C, Julian-Reynier C, Eisinger F, Stoppa-Lyonnet D, Bressac-de Paillerets B, Sobol H, Moatti JP., Int J Technol Assess Health Care 19(2), 2003
PMID: 12862187

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0
A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers.
Arnold N, Gross E, Schwarz-Boeger U, Pfisterer J, Jonat W, Kiechle M., Hum. Mutat. 14(4), 1999
PMID: 10502781
Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1.
Eng C, Brody LC, Wagner TM, Devilee P, Vijg J, Szabo C, Tavtigian SV, Nathanson KL, Ostrander E, Frank TS; Steering Committee of the Breast Cancer Information Core (BIC) Consortium., J. Med. Genet. 38(12), 2001
PMID: 11748305

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, J Clin Oncol 14(), 1996

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0
Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families.
Rothfuss A, Schutz P, Bochum S, Volm T, Eberhardt E, Kreienberg R, Vogel W, Speit G., Cancer Res. 60(2), 2000
PMID: 10667592
Detection of germline mutations in the BRCA1 gene by RNA-based sequencing.
Jakubowska A, Gorski B, Byrski T, Huzarski T, Gronwald J, Menkiszak J, Cybulski C, Debniak T, Hadaczek P, Scott RJ, Lubinski J., Hum. Mutat. 18(2), 2001
PMID: 11462239
Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations.
Andrulis IL, Anton-Culver H, Beck J, Bove B, Boyd J, Buys S, Godwin AK, Hopper JL, Li F, Neuhausen SL, Ozcelik H, Peel D, Santella RM, Southey MC, van Orsouw NJ, Venter DJ, Vijg J, Whittemore AS; Cooperative Family Registry for Breast Cancer studies., Hum. Mutat. 20(1), 2002
PMID: 12112659
Detection of germline BRCA1 mutations by Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) method.
Casadei S, Cortesi L, Pensotti V, Radice P, Pierotti M, Amadori D, Calistri D., Br. J. Cancer 85(6), 2001
PMID: 11556835
BRCA1 mutation screening using restriction endonuclease fingerprinting-single-strand conformation polymorphism in an automated capillary electrophoresis system.
Kringen P, Egedal S, Pedersen JC, Harbitz TB, Tveit KM, Berg K, Borresen-Dale AL, Andersen TI., Electrophoresis 23(24), 2002
PMID: 12481264
A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC.
Gross E, Arnold N, Goette J, Schwarz-Boeger U, Kiechle M., Hum. Genet. 105(1-2), 1999
PMID: 10480358
Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1and BRCA2genes in familial breast cancer.
Sakayori M, Kawahara M, Shiraishi K, Nomizu T, Shimada A, Kudo T, Abe R, Ohuchi N, Takenoshita S, Kanamaru R, Ishioka C., J. Hum. Genet. 48(3), 2003
PMID: 12624724
Predicting DNA duplex stability from the base sequence.
Breslauer KJ, Frank R, Blocker H, Marky LA., Proc. Natl. Acad. Sci. U.S.A. 83(11), 1986
PMID: 3459152
Empirical evidence of design-related bias in studies of diagnostic tests.
Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, Bossuyt PM., JAMA 282(11), 1999
PMID: 10493205
Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.
Lewis AG, Flanagan J, Marsh A, Pupo GM, Mann G, Spurdle AB, Lindeman GJ, Visvader JE, Brown MA, Chenevix-Trench G; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer., Breast Cancer Res. 7(6), 2005
PMID: 16280053
German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer.
Rashid MU, Jakubowska A, Justenhoven C, Harth V, Pesch B, Baisch C, Pierl CB, Bruning T, Ko Y, Benner A, Wichmann HE, Brauch H, Hamann U; GENICA Network., Eur. J. Cancer 41(18), 2005
PMID: 16239104
The 471delAAAG mutation and C353T polymorphism in the RNASEL gene in sporadic and inherited cancer in Israel.
Dagan E, Laitman Y, Levanon N, Feuer A, Sidi AA, Baniel J, Korach Y, Ben Baruch G, Friedman E, Gershoni-Baruch R., Fam. Cancer 5(4), 2006
PMID: 16944274
Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method.
Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R, Regnerus R, van Welsem T, van Spaendonk R, Menko FH, Kluijt I, Dommering C, Verhoef S, Schouten JP, van't Veer LJ, Pals G., Cancer Res. 63(7), 2003
PMID: 12670888
Bar code screening on combed DNA for large rearrangements of the BRCA1 and BRCA2 genes in French breast cancer families.
Gad S, Klinger M, Caux-Moncoutier V, Pages-Berhouet S, Gauthier-Villars M, Coupier I, Bensimon A, Aurias A, Stoppa-Lyonnet D., J. Med. Genet. 39(11), 2002
PMID: 12414821
DFold: PCR design that minimizes secondary structure and optimizes downstream genotyping applications.
Fredman D, Jobs M, Stromqvist L, Brookes AJ., Hum. Mutat. 24(1), 2004
PMID: 15221783

AUTHOR UNKNOWN, 0

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 17342152
PubMed | Europe PMC

Suchen in

Google Scholar